- Report
- March 2025
- 200 Pages
Global
From €3942EUR$4,490USD£3,429GBP
- Report
- February 2025
- 200 Pages
Global
From €3942EUR$4,490USD£3,429GBP
- Report
- January 2025
- 180 Pages
Global
From €3951EUR$4,500USD£3,436GBP
- Report
- December 2024
Global
From €6585EUR$7,500USD£5,727GBP
- Report
- November 2024
- 80 Pages
North America
From €3029EUR$3,450USD£2,635GBP
- Report
- January 2023
- 197 Pages
Global
From €4346EUR$4,950USD£3,780GBP
- Report
- April 2018
- 97 Pages
Global
From €14047EUR$16,000USD£12,219GBP
- Report
- September 2023
- 190 Pages
Global
From €2186EUR$2,490USD£1,902GBP
- Report
- October 2023
- 183 Pages
Global
From €3951EUR$4,500USD£3,436GBP
- Book
- October 2018
- 308 Pages
Stomach cancer, also known as gastric cancer, is a type of cancer that affects the lining of the stomach. It is the fourth most common cancer worldwide and is the second leading cause of cancer-related death. Symptoms of stomach cancer can include abdominal pain, nausea, vomiting, and weight loss. Diagnosis is typically made through endoscopy, biopsy, and imaging tests. Treatment options include surgery, chemotherapy, and radiation therapy.
Gastroenterology is a medical specialty that focuses on the diagnosis and treatment of diseases of the digestive system. Gastroenterologists are experts in the diagnosis and treatment of stomach cancer, as well as other digestive diseases.
Companies in the stomach cancer market include AstraZeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more
